CLINICAL_TRIALS
research
· 2026-03-30
Clinical Trial Update: A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 clinical trial to compare two different versions of injectable CagriSema in adults with Type 2 diabetes; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: NOT_YET_RECRUITING